Zenagamtide

Intervention1 paper1 finding

Outcomes

1

Body weight

downin humans1−13%

1 study

Zenagamtide decreases body weight in humans (up to 13.1%).
Revieworal85 days
New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus · Diabetes therapy : research, treatment and education of diabetes and related disorders · 28 Sep 2026

Latest

1

Diabetes TherapyReview29 Sep

New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus